Delivery Order SPE2DB20D3103-SPE2DB25FP6S8
- Not listed
- This is a $107,355.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, with a performance period through January 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This delivery order, valued at $191,366.72, was awarded on July 23, 2025, to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. The contract is non-set-aside and firm fixed price in nature, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this award. The contract is funded through the Medical Supply Chain division of the Department...
- The Defense Logistics Agency has awarded a delivery order valued at $59,802.10 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 IU 15ml pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $198,735.12 firm fixed price delivery order contract to AmerisourceBergen Drug Corp. This contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The award has an ultimate completion date of August 19, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the...
- This is a $45,689.76 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on December 13, 2024. The order is for the supply of 4,566,716,735 units of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency awarded a delivery order valued at $5,060.79 to AmerisourceBergen Drug Corp for the supply of DARZALEX 400 mg/20 mL vials. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating the contract was competed among qualified vendors in the open market. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $33,122.52 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,563,692,912 units of DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceuticals. The contract has a completion date of March 11, 2024 and was awarded on February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,122.52 firm fixed price contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, with a performance period through December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,643.39 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml, a specialized pharmaceutical product. This firm fixed-price delivery order, issued on July 23, 2025, is scheduled for completion by August 13, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive delivery against an existing indefinite delivery...
- This is a $11,960.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the drug product DARZALEX FASPRO 1,800MG-30,000 15ML, with a completion date of July 15, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides global...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6S8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $71,762.52 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product for military healthcare systems. This firm fixed-price delivery order, awarded on July 28, 2025, carries an ultimate completion date of August 18, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal procurement standards through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As the prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with this delivery order representing one component of its substantial pharmaceutical distribution responsibilities within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $71.8k | 7/28/25 |